Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Small Cell Lung Carcinoma × amrubicin × Clear all

Phase

Status

Completed 6 Terminated 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Carboplatin 15 Etoposide 13 durvalumab 12 atezolizumab 8 Nivolumab 8 pembrolizumab 7 Cisplatin 7 Topotecan 6 Specimen Handling 5 olaparib 4 berzosertib 4 Temozolomide 4 tremelimumab 3 Radiosurgery 3 PM 01183 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Biopsy 3 AMG 757 3 niraparib 2 cabozantinib 2 Platinum 2 Irinotecan 2 Docetaxel 2 veliparib 1 tazemetostat 1 talazoparib 1 palbociclib 1 lenvatinib 1 futibatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05740566 2026-01-05

DeLLphi-304

Amgen

Phase 3 Active not recruiting

509 enrolled 11 charts 1 FDA

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡